N/A
Completed N=72
Trial Comparing 19 and 25-gauge EUS-FNA Needles
Source: ClinicalTrials.gov NCT01677312 ↗Enrolled (actual)
72
Serious AEs
0.0%
Results posted
Mar 2020
Primary outcomePrimary: Median Number of Passes to Establish Diagnosis — 1; 1 No. of passes
Summary
This study compares the 19G and 25G needles for procuring tissue samples from the pancreas during Endoscopic Ultrasound (EUS) procedures.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Median Number of Passes to Establish Diagnosis |
1; 1 | — |
| SECONDARY Procurement of Histological Samples |
86.1; 33.3 | — |
| SECONDARY Needle Dysfunction |
0; 2.8 | — |
| SECONDARY Complications |
2.8; 0 | — |
Eligibility Criteria
INCLUSION CRITERIA
(1) Patients with solid pancreatic mass lesions.
EXCLUSION CRITERIA
- Age 1.6, Prothrombin Time > 18secs, Thrombocytopenia < 80,000 cells/ml)
- Unable to consent
- Non-English speaking patients
Data sourced from ClinicalTrials.gov (NCT01677312). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.